EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.58 Million EUR | -168.3% |
| 2022 | -323 Thousand EUR | -55.63% |
| 2021 | 309 Thousand EUR | -344.04% |
| 2020 | 2.37 Million EUR | -21.12% |
| 2019 | 2.06 Million EUR | 211.39% |
| 2018 | 295 Thousand EUR | -65.74% |
| 2017 | 1.32 Million EUR | -488.19% |
| 2016 | 1.38 Million EUR | 235.85% |
| 2015 | 1.45 Million EUR | 83.77% |
| 2014 | 569 Thousand EUR | 14.36% |
| 2013 | -1.74 Million EUR | 56.88% |
| 2012 | -1.14 Million EUR | -20.76% |
| 2011 | -2.92 Million EUR | 37.69% |
| 2010 | -8.4 Million EUR | -308.43% |
| 2009 | -4.43 Million EUR | 54.42% |
| 2008 | 4.84 Million EUR | -107.87% |
| 2007 | -3.89 Million EUR | -7.09% |
| 2006 | -1.13 Million EUR | -226.87% |
| 2005 | -119.89 Thousand EUR | -156.47% |
| 2004 | 614.48 Thousand EUR | 109.57% |
| 2003 | -7.12 Million EUR | -47.76% |
| 2002 | -3.66 Million EUR | 71.11% |
| 2001 | -3.22 Million EUR | 28.87% |
| 2000 | -2.39 Million EUR | -158.78% |
| 1999 | -6.32 Million EUR | -139.66% |
| 1998 | -4.6 Million EUR | -837.93% |
| 1997 | 636.36 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.17 Million EUR | -30.65% |
| 2024 Q1 | -4.84 Million EUR | -72.24% |
| 2023 Q4 | -2.51 Million EUR | 63.25% |
| 2023 Q1 | -5.41 Million USD | -316.01% |
| 2023 Q3 | -6.85 Million EUR | -84.42% |
| 2023 FY | - EUR | -168.3% |
| 2023 Q2 | -3.71 Million EUR | 31.31% |
| 2022 Q1 | -680 Thousand EUR | -109.23% |
| 2022 FY | - EUR | -55.63% |
| 2022 Q4 | 2.5 Million EUR | 148.46% |
| 2022 Q3 | -5.16 Million EUR | -82.01% |
| 2022 Q2 | -2.84 Million EUR | -317.65% |
| 2021 FY | - EUR | -344.04% |
| 2021 Q4 | -325 Thousand EUR | 88.75% |
| 2021 Q3 | -2.88 Million EUR | -467.39% |
| 2021 Q2 | -509 Thousand EUR | -103.6% |
| 2021 Q1 | -250 Thousand EUR | -110.22% |
| 2020 Q3 | 281 Thousand EUR | -56.7% |
| 2020 Q1 | -1.74 Million EUR | -339.26% |
| 2020 Q2 | 649 Thousand EUR | 137.11% |
| 2020 FY | - EUR | -21.12% |
| 2020 Q4 | 2.44 Million EUR | 770.82% |
| 2019 Q1 | -57 Thousand EUR | -109.12% |
| 2019 Q2 | 1.81 Million EUR | 3284.21% |
| 2019 Q4 | 731 Thousand EUR | -45.2% |
| 2019 FY | - EUR | 211.39% |
| 2019 Q3 | 1.33 Million EUR | -26.5% |
| 2018 Q4 | 625 Thousand EUR | 215.96% |
| 2018 FY | - EUR | -65.74% |
| 2018 Q3 | -539 Thousand EUR | 65.23% |
| 2018 Q2 | -1.55 Million EUR | -300.52% |
| 2018 Q1 | -387 Thousand EUR | -760.0% |
| 2017 Q2 | 195 Thousand EUR | 132.77% |
| 2017 Q4 | -45 Thousand EUR | 93.33% |
| 2017 FY | - EUR | -488.19% |
| 2017 Q1 | -595 Thousand EUR | -157.6% |
| 2017 Q3 | -675 Thousand EUR | -446.15% |
| 2016 Q4 | 1.03 Million EUR | 324.08% |
| 2016 FY | - EUR | 235.85% |
| 2016 Q2 | -828 Thousand EUR | -251.93% |
| 2016 Q1 | 545 Thousand EUR | -50.86% |
| 2016 Q3 | -461 Thousand EUR | 44.32% |
| 2015 Q2 | 45 Thousand EUR | 103.79% |
| 2015 Q3 | -176 Thousand EUR | -491.11% |
| 2015 Q4 | 1.1 Million EUR | 730.11% |
| 2015 FY | - EUR | 83.77% |
| 2015 Q1 | -1.18 Million EUR | -89.31% |
| 2014 Q2 | -1.76 Million EUR | -451.09% |
| 2014 Q3 | 584 Thousand EUR | 133.07% |
| 2014 Q4 | -627 Thousand EUR | -207.36% |
| 2014 Q1 | 503 Thousand EUR | 60.19% |
| 2014 FY | - EUR | 14.36% |
| 2013 Q3 | 52 Thousand EUR | 105.69% |
| 2013 FY | - EUR | 56.88% |
| 2013 Q1 | -978 Thousand EUR | 55.14% |
| 2013 Q4 | 314 Thousand EUR | 503.85% |
| 2013 Q2 | -914 Thousand EUR | 6.54% |
| 2012 Q4 | -2.18 Million EUR | -592.06% |
| 2012 FY | - EUR | -20.76% |
| 2012 Q3 | -315 Thousand EUR | 73.6% |
| 2012 Q1 | -745 Thousand EUR | -1519.57% |
| 2012 Q2 | -1.19 Million EUR | -60.13% |
| 2011 Q4 | -46 Thousand EUR | 93.76% |
| 2011 Q2 | -1.6 Million EUR | -590.95% |
| 2011 Q1 | -232 Thousand EUR | -133.33% |
| 2011 FY | - EUR | 37.69% |
| 2011 Q3 | -737 Thousand EUR | 54.02% |
| 2010 FY | - EUR | -308.43% |
| 2010 Q4 | 696 Thousand EUR | 327.45% |
| 2010 Q1 | -1.84 Million EUR | -2084.95% |
| 2010 Q2 | -2.09 Million EUR | -13.49% |
| 2010 Q3 | -306 Thousand EUR | 85.39% |
| 2009 Q3 | -1.56 Million EUR | -387.27% |
| 2009 Q1 | -1.15 Million EUR | -657.0% |
| 2009 FY | - EUR | 54.42% |
| 2009 Q4 | 93 Thousand EUR | 105.93% |
| 2009 Q2 | -322 Thousand EUR | 72.07% |
| 2008 Q1 | -1.82 Million EUR | -294.28% |
| 2008 FY | - EUR | -107.87% |
| 2008 Q4 | 207 Thousand EUR | 112.65% |
| 2008 Q3 | -1.63 Million EUR | -13.47% |
| 2008 Q2 | -1.44 Million EUR | 20.96% |
| 2007 Q1 | 4.6 Million EUR | 353.42% |
| 2007 Q2 | 5.95 Million EUR | 29.22% |
| 2007 Q3 | 1.61 Million EUR | -72.81% |
| 2007 FY | - EUR | -7.09% |
| 2007 Q4 | 938.96 Thousand EUR | -41.97% |
| 2006 Q1 | -404.25 Thousand EUR | 93.3% |
| 2006 Q4 | -1.81 Million EUR | -144.56% |
| 2006 Q3 | -743.04 Thousand EUR | 9.58% |
| 2006 Q2 | -821.73 Thousand EUR | -103.27% |
| 2006 FY | - EUR | -226.87% |
| 2005 Q2 | 1.59 Million EUR | -2.32% |
| 2005 Q1 | 1.62 Million EUR | 127.3% |
| 2005 FY | - EUR | -156.47% |
| 2005 Q4 | -6.03 Million EUR | -518.3% |
| 2005 Q3 | 1.44 Million EUR | -9.29% |
| 2004 Q1 | 5.65 Million EUR | 154.98% |
| 2004 Q4 | -5.96 Million EUR | -419.29% |
| 2004 Q2 | 1.64 Million EUR | -70.98% |
| 2004 FY | - EUR | 109.57% |
| 2004 Q3 | 1.86 Million EUR | 13.82% |
| 2003 Q3 | 599.63 Thousand EUR | -24.76% |
| 2003 Q1 | 842.94 Thousand EUR | 110.38% |
| 2003 Q2 | 796.97 Thousand EUR | -5.45% |
| 2003 Q4 | -10.28 Million EUR | -1815.37% |
| 2003 FY | - EUR | -47.76% |
| 2002 Q4 | -8.12 Million EUR | -1094.09% |
| 2002 FY | - EUR | 71.11% |
| 2002 Q3 | 817.21 Thousand EUR | -81.78% |
| 2002 Q2 | 4.48 Million EUR | -11.09% |
| 2002 Q1 | 5.04 Million EUR | 123.78% |
| 2001 Q3 | 5.21 Million EUR | -18.2% |
| 2001 Q2 | 6.38 Million EUR | 7.76% |
| 2001 Q1 | 5.92 Million EUR | 124.52% |
| 2001 FY | - EUR | 28.87% |
| 2001 Q4 | -21.21 Million EUR | -506.45% |
| 2000 Q3 | 7.93 Million EUR | 33.65% |
| 2000 Q1 | 5.55 Million EUR | 124.16% |
| 2000 Q2 | 5.93 Million EUR | 6.91% |
| 2000 FY | - EUR | -158.78% |
| 2000 Q4 | -24.15 Million EUR | -404.34% |
| 1999 Q2 | 4.82 Million EUR | -18.77% |
| 1999 FY | - EUR | -139.66% |
| 1999 Q1 | 5.94 Million EUR | 126.71% |
| 1999 Q4 | -22.98 Million EUR | -646.2% |
| 1999 Q3 | 4.2 Million EUR | -12.85% |
| 1998 Q3 | 3.73 Million EUR | -48.11% |
| 1998 Q1 | 6.12 Million EUR | 126.23% |
| 1998 FY | - EUR | -837.93% |
| 1998 Q4 | -22.26 Million EUR | -696.25% |
| 1998 Q2 | 7.19 Million EUR | 17.41% |
| 1997 Q3 | 8.2 Million EUR | 81.28% |
| 1997 Q4 | -23.36 Million EUR | -384.69% |
| 1997 FY | - EUR | 0.0% |
| 1997 Q1 | 4.56 Million EUR | 0.0% |
| 1997 Q2 | 4.52 Million EUR | -0.91% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alphatec Holdings, Inc. | -110.59 Million USD | 85.0% |
| Nemaura Medical Inc. | -7.28 Million USD | -127.65% |
| NeuroPace, Inc. | -22.83 Million USD | 27.35% |
| LENSAR, Inc. | -8.71 Million USD | -90.372% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 69.141% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 71.544% |
| Apyx Medical Corporation | -18.11 Million USD | 8.409% |
| Cutera, Inc. | -136.56 Million USD | 87.852% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -390.799% |
| BioSig Technologies, Inc. | -28.15 Million USD | 41.071% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 66.669% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 104.325% |
| Axonics, Inc. | 7.77 Million USD | 313.363% |
| IRIDEX Corporation | -7.44 Million USD | -122.731% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 83.089% |
| TELA Bio, Inc. | -40.63 Million USD | 59.174% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -105.768% |
| RxSight, Inc. | -41.03 Million USD | 59.576% |
| Align Technology, Inc. | 799.03 Million USD | 102.076% |
| INVO Bioscience, Inc. | -6.88 Million USD | -141.118% |
| electroCore, Inc. | -17.76 Million USD | 6.593% |
| Telesis Bio, Inc. | -40.49 Million USD | 59.032% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 145.23% |
| Quipt Home Medical Corp. | 44.07 Million USD | 137.642% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 759.34% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -52.613% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 66.656% |
| Dynatronics Corporation | -976 Thousand USD | -1599.679% |
| Modular Medical, Inc. | -17.1 Million USD | 3.005% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -14.525% |
| Talis Biomedical Corporation | -66.04 Million USD | 74.882% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -58.073% |
| InMode Ltd. | 196.28 Million USD | 108.452% |
| Envoy Medical, Inc. | -18.23 Million USD | 9.042% |
| Bruker Corporation | 599 Million USD | 102.769% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -37.02% |
| DexCom, Inc. | 916.7 Million USD | 101.81% |
| Nexalin Technology, Inc. | -5.69 Million USD | -191.442% |
| PAVmed Inc | -75.74 Million USD | 78.098% |
| Viveve Medical, Inc. | -20.61 Million USD | 19.537% |
| Cerus Corporation | -26.53 Million USD | 37.485% |
| Movano Inc. | -29.12 Million USD | 43.042% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -276.339% |
| Nexalin Technology, Inc. | -5.69 Million USD | -191.442% |
| IceCure Medical Ltd | -15.25 Million USD | -8.759% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 91.478% |
| enVVeno Medical Corporation | -25.01 Million USD | 33.692% |
| 908 Devices Inc. | -34.02 Million USD | 51.245% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 20.963% |
| Orthofix Medical Inc. | -86.98 Million USD | 80.929% |
| Surmodics, Inc. | 1.18 Million USD | 1496.38% |
| Nuwellis, Inc. | -16.35 Million USD | -1.425% |
| Outset Medical, Inc. | -153.78 Million USD | 89.213% |
| Venus Concept Inc. | -26.11 Million USD | 36.472% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 82.874% |
| Treace Medical Concepts, Inc. | -39 Million USD | 57.473% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 65.217% |
| Aethlon Medical, Inc. | -11.84 Million USD | -40.002% |
| Inogen, Inc. | -45.67 Million USD | 63.684% |
| IRadimed Corporation | 20.8 Million USD | 179.752% |
| MaxCyte, Inc. | -44.12 Million USD | 62.407% |
| Pulmonx Corporation | -55.09 Million USD | 69.889% |
| PAVmed Inc. | -75.74 Million USD | 78.098% |
| iCAD, Inc. | -6.56 Million USD | -152.688% |
| OrthoPediatrics Corp. | -8.38 Million USD | -97.936% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -370.21% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 1.582% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -41.111% |
| SI-BONE, Inc. | -34.44 Million USD | 51.841% |
| Semler Scientific, Inc. | 23.58 Million USD | 170.325% |
| Beyond Air, Inc. | -59.03 Million USD | 71.898% |
| FONAR Corporation | 28.25 Million USD | 158.719% |
| AxoGen, Inc. | -13.32 Million USD | -24.467% |
| Biotricity, Inc. | -8.82 Million USD | -87.908% |
| Cytosorbents Corporation | -28.81 Million USD | 42.421% |
| ZimVie Inc. | 91.07 Million USD | 118.215% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 167.597% |
| Inari Medical, Inc. | 7.11 Million USD | 333.221% |
| UFP Technologies, Inc. | 72.74 Million USD | 122.805% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -370.21% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -389.96% |
| Sight Sciences, Inc. | -49.41 Million USD | 66.429% |
| Insulet Corporation | 323.6 Million USD | 105.126% |
| Profound Medical Corp. | -27.12 Million USD | 38.839% |
| Bioventus Inc. | -23.07 Million USD | 28.093% |
| InspireMD, Inc. | -20.91 Million USD | 20.669% |
| BrainsWay Ltd. | -2.31 Million USD | -617.828% |
| BIOLASE, Inc. | -15.13 Million USD | -9.578% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -169.477% |
| Tenon Medical, Inc. | -15.52 Million USD | -6.833% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -8.666% |
| CVRx, Inc. | -38.73 Million USD | 57.169% |
| AdaptHealth Corp. | -171.09 Million USD | 90.304% |
| Sintx Technologies, Inc. | -6.6 Million USD | -151.348% |
| Acutus Medical, Inc. | -13.48 Million USD | -23.0% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 0.516% |
| NanoVibronix, Inc. | -3.43 Million USD | -382.94% |
| Quanterix Corporation | -38.08 Million USD | 56.446% |
| LivaNova PLC | 39.01 Million USD | 142.518% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 60.003% |
| Varex Imaging Corporation | 67.2 Million USD | 124.686% |
| Vivani Medical, Inc. | -26.6 Million USD | 37.654% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -52.613% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 55396.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 94.017% |
| TransMedics Group, Inc. | -7.6 Million USD | -118.19% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 23.781% |
| NeuroMetrix, Inc. | -7.09 Million USD | -133.786% |
| Spectral AI, Inc. | -12.26 Million USD | -35.288% |
| Hyperfine, Inc. | -47.06 Million USD | 64.75% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 71.549% |
| Biomerica, Inc. | -5.99 Million USD | -176.806% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3559.126% |
| AVITA Medical, Inc. | -39.56 Million USD | 58.074% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -80.847% |
| Silk Road Medical, Inc | -45.08 Million USD | 63.201% |